In this study, we found that the RELN gene was highly methylated in HCC tumor tissues and sorafenib-resistant HCC cells, and the demethylation of the RELN gene reversed the effect of sorafenib on HCC cells. This evidence concerns the gene RELN and hepatocellular carcinoma.